BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 25736276)

  • 1. The role of screening and monitoring for bleomycin pulmonary toxicity.
    Shippee BM; Bates JS; Richards KL
    J Oncol Pharm Pract; 2016 Apr; 22(2):308-12. PubMed ID: 25736276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence, outcome and predictors of bleomycin pulmonary toxicity in a university hospital in Oman.
    Ahmed BM; Al-Zakwani IS
    J Oncol Pharm Pract; 2013 Mar; 19(1):3-7. PubMed ID: 22504168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevation of the erythrocyte sedimentation rate precedes exacerbation of bleomycin-induced pulmonary toxicity: report of two cases and review of literature.
    Higa GM; AlKhouri N; Auber ML
    Pharmacotherapy; 1997; 17(6):1315-21. PubMed ID: 9399618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bleomycin induced pulmonary toxicity in patients with germ cell tumours.
    Usman M; Faruqui ZS; ud Din N; Zahid KF
    J Ayub Med Coll Abbottabad; 2010; 22(3):35-7. PubMed ID: 22338413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late pulmonary complications of treating Hodgkin lymphoma: bleomycin-induced toxicity.
    Jóna Á; Miltényi Z; Ujj Z; Garai I; Szilasi M; Illés Á
    Expert Opin Drug Saf; 2014 Oct; 13(10):1291-7. PubMed ID: 25135756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bleomycin-induced pulmonary toxicity in chemotherapy for testicular cancer.
    Kawai K; Akaza H
    Expert Opin Drug Saf; 2003 Nov; 2(6):587-96. PubMed ID: 14585067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late pulmonary toxicity of bleomycin.
    Willenbacher W; Mumm A; Bartsch HH
    J Clin Oncol; 1998 Sep; 16(9):3205. PubMed ID: 9738596
    [No Abstract]   [Full Text] [Related]  

  • 8. Life threatening lung toxicity induced by low doses of bleomycin in a patient with Hodgkin's disease.
    Real E; Roca MJ; Viñuales A; Pastor E; Grau E
    Haematologica; 1999 Jul; 84(7):667-8. PubMed ID: 10406918
    [No Abstract]   [Full Text] [Related]  

  • 9. Pulmonary toxicity due to bleomycin. Report of a case.
    Krous HF; Hamlin WB
    Arch Pathol; 1973 Jun; 95(6):407-10. PubMed ID: 4121790
    [No Abstract]   [Full Text] [Related]  

  • 10. The pulmonary changes of bleomycin toxicity.
    Horowitz AL; Friedman M; Smith J; Yagoda A; LaMonte C; Watson RC
    Radiology; 1973 Jan; 106(1):65-8. PubMed ID: 4118845
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pulmonary cytotoxicity induced by bleomycin and methotrexate].
    Sheĭkh ZhV; Krutskevich AO; Drebushevskiĭ NS; Shvaĭko SN; Dunaev AP; Alekseev VG
    Vestn Rentgenol Radiol; 2015; (3):46-51. PubMed ID: 26302622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Bleomycin Administration on the Development of Pulmonary Toxicity in Patients With Metastatic Germ Cell Tumors Receiving First-Line Chemotherapy: A Meta-Analysis of Randomized Studies.
    Necchi A; Miceli R; Oualla K; Sonpavde G; Giannatempo P; Raggi D; Nicolai N; Boffi R; Busia A; Mariani L; Salvioni R
    Clin Genitourin Cancer; 2017 Apr; 15(2):213-220.e5. PubMed ID: 27692810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bleomycin and pulmonary screening: many questions, few answers.
    Duncan CN
    Pediatr Blood Cancer; 2014 Sep; 61(9):1527-8. PubMed ID: 24810221
    [No Abstract]   [Full Text] [Related]  

  • 14. Bleomycin: pulmonary toxicity.
    Rudders RA
    Ann Intern Med; 1973 Apr; 78(4):618. PubMed ID: 4121001
    [No Abstract]   [Full Text] [Related]  

  • 15. Pulmonary toxicity of bleomycin: is G-CSF a risk factor?
    Bastion Y; Coiffier B
    Lancet; 1994 Aug; 344(8920):474. PubMed ID: 7520108
    [No Abstract]   [Full Text] [Related]  

  • 16. Cytotoxic drug-induced lung disease.
    Sostman HD; Matthay RA; Putman CE
    Am J Med; 1977 Apr; 62(4):608-15. PubMed ID: 66869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pulmonary changes due to bleomycin. Radiologic study].
    Dragoni G; Guzzon A; Bonadonna G
    Radiol Med; 1971 Jul; 57(7):497-510. PubMed ID: 4112551
    [No Abstract]   [Full Text] [Related]  

  • 18. [Consortium for detection and management of lung damage induced by bleomycin].
    Biya J; Stoclin A; Dury S; Le Pavec J; Mir O; Lazarovici J; Fermé C; Annereau M; Ekpe K; Massard C; Michot JM
    Bull Cancer; 2016; 103(7-8):651-61. PubMed ID: 27241272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective study of the pulmonary toxicity of continuously infused bleomycin.
    Cooper KR; Hong WK
    Cancer Treat Rep; 1981; 65(5-6):419-25. PubMed ID: 6165471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting the risk of bleomycin lung toxicity in patients with germ-cell tumours.
    O'Sullivan JM; Huddart RA; Norman AR; Nicholls J; Dearnaley DP; Horwich A
    Ann Oncol; 2003 Jan; 14(1):91-6. PubMed ID: 12488299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.